Skip to main content
Erschienen in: Journal of Nuclear Cardiology 4/2019

06.12.2017 | Original Article

Coronary risk equivalence of diabetes assessed by SPECT-MPI

verfasst von: Donna Chelle V. Morales, DO, Sanjeev P. Bhavnani, MD, Alan W. Ahlberg, MA, Raja C. Pullatt, MD, Deborah M. Katten, RN, MPH, Donna M. Polk, MD, MPH, Gary V. Heller, MD, PhD

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Several publications and guidelines designate diabetes mellitus (DM) as a coronary artery disease (CAD) risk equivalent. The aim of this investigation was to examine DM cardiac risk equivalence from the perspective of stress SPECT myocardial perfusion imaging (MPI).

Methods and Results

We examined cardiovascular outcomes (cardiac death or nonfatal MI) of 17,499 patients referred for stress SPECT-MPI. Patients were stratified into four categories: non-DM without CAD, non-DM with CAD, DM without CAD, and DM with CAD, and normal or abnormal perfusion. Cardiac events occurred in 872 (5%), with event-free survival best among non-DM without CAD, worst in DM with CAD, and intermediate in DM without CAD, and non-DM with CAD. After multivariate adjustment, risk remained comparable between DM without CAD and non-DM with CAD [AHR 1.0 (95% CI 0.84–1.28), P =0.74]. Annualized event rates for normal subjects were 1.4% and 1.6% for non-DM with CAD and DM without CAD, respectively (P = 0.48) and 3.5% (P = 0.95) for both abnormal groups. After multivariate adjustment, outcomes were comparable within normal [AHR 1.4 (95% CI 0.98–1.96) P = 0.06] and abnormal [AHR 1.1 (95% CI 0.83–1.50) P = 0.49] MPI.

Conclusions

Diabetic patients without CAD have comparable risk of cardiovascular events as non-diabetic patients with CAD after stratification by MPI results. These findings support diabetes as a CAD equivalent and suggest that MPI provides additional prognostic information in such patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Danaei G, Finucane MM, Lu Y, et al. on behalf of the Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31–40.CrossRefPubMed Danaei G, Finucane MM, Lu Y, et al. on behalf of the Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31–40.CrossRefPubMed
2.
Zurück zum Zitat Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham Study. Diabet Care. 1979;2:120–6.CrossRef Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham Study. Diabet Care. 1979;2:120–6.CrossRef
3.
Zurück zum Zitat Krempf M, Parhofer KG, Steg G, et al. Reach Registry Investigators. Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry). Am J Cardiol. 2010;105:667–71.CrossRefPubMed Krempf M, Parhofer KG, Steg G, et al. Reach Registry Investigators. Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry). Am J Cardiol. 2010;105:667–71.CrossRefPubMed
4.
Zurück zum Zitat Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–34.CrossRefPubMed Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–34.CrossRefPubMed
5.
Zurück zum Zitat De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European Society of Cardiology Committee for Practice Guidelines. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2003;10(4):S1.CrossRefPubMed De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European Society of Cardiology Committee for Practice Guidelines. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2003;10(4):S1.CrossRefPubMed
6.
Zurück zum Zitat Smith SC, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. J Am Coll Cardiol. 2006;47:2130–9.CrossRefPubMed Smith SC, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. J Am Coll Cardiol. 2006;47:2130–9.CrossRefPubMed
7.
Zurück zum Zitat Hu FB, Stampfer MJ, Solomon CG, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease mortality in women: 20 yr of follow-up. Arch Intern Med. 2001;161:1717–23.CrossRefPubMed Hu FB, Stampfer MJ, Solomon CG, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease mortality in women: 20 yr of follow-up. Arch Intern Med. 2001;161:1717–23.CrossRefPubMed
8.
Zurück zum Zitat Natarajan S, Liao Y, Sinha D, Cao G, McGee DL, Lipsitz SR. Sex differences in the effect of diabetes duration on coronary heart disease mortality. Arch Intern Med. 2005;165:430–5.CrossRefPubMed Natarajan S, Liao Y, Sinha D, Cao G, McGee DL, Lipsitz SR. Sex differences in the effect of diabetes duration on coronary heart disease mortality. Arch Intern Med. 2005;165:430–5.CrossRefPubMed
9.
Zurück zum Zitat Whitely L, Padmanabhan S, Hole D, Isles C. Should diabetes be considered a coronary heart disease risk equivalent? Diabetes Care. 2005;28:1588–93.CrossRef Whitely L, Padmanabhan S, Hole D, Isles C. Should diabetes be considered a coronary heart disease risk equivalent? Diabetes Care. 2005;28:1588–93.CrossRef
10.
Zurück zum Zitat Carnethon MR, Biggs ML, Barzilay J, et al. Diabetes and coronary heart disease as risk factors for mortality in older adults. Am J Med. 2010;123(6):6.e1-9.CrossRef Carnethon MR, Biggs ML, Barzilay J, et al. Diabetes and coronary heart disease as risk factors for mortality in older adults. Am J Med. 2010;123(6):6.e1-9.CrossRef
11.
Zurück zum Zitat Hadaegh F, Fahimfar N, Khalili D, Sheikholeslami F, Azizi F. New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population. Cardiovasc Diabetol. 2010;9:84.CrossRefPubMedPubMedCentral Hadaegh F, Fahimfar N, Khalili D, Sheikholeslami F, Azizi F. New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population. Cardiovasc Diabetol. 2010;9:84.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Malmberg K, Yusuf S, Gerstein HC, et al. OASIS Registry Investigators. Impact of diabetes on long term prognosis in patients with unstable angina and non-q-wave myocardial infarction. Circulation. 2000;102:1014–9.CrossRefPubMed Malmberg K, Yusuf S, Gerstein HC, et al. OASIS Registry Investigators. Impact of diabetes on long term prognosis in patients with unstable angina and non-q-wave myocardial infarction. Circulation. 2000;102:1014–9.CrossRefPubMed
13.
Zurück zum Zitat Lee CD, Folsom AR, Pankow JS, Brancati FL. Atherosclerosis Risk In Communities (ARIC) study investigators. Cardiovascular events in diabetic and non-diabetic adults with or without history of myocardial infarction. Circulation. 2004;109:855–60.CrossRefPubMed Lee CD, Folsom AR, Pankow JS, Brancati FL. Atherosclerosis Risk In Communities (ARIC) study investigators. Cardiovascular events in diabetic and non-diabetic adults with or without history of myocardial infarction. Circulation. 2004;109:855–60.CrossRefPubMed
14.
Zurück zum Zitat Evans JM, Wang J, Morris AD. Comparison of cardiovascular risk between patients with Type 2 diabetes mellitus and those who had myocardial infarction: cross-sectional and cohort studies. Br Med J. 2002;324:939–42.CrossRef Evans JM, Wang J, Morris AD. Comparison of cardiovascular risk between patients with Type 2 diabetes mellitus and those who had myocardial infarction: cross-sectional and cohort studies. Br Med J. 2002;324:939–42.CrossRef
15.
Zurück zum Zitat Lotufo PA, Gaziano JM, Chae CU, et al. Diabetes and all cause and coronary heart disease mortality among US male physicians. Arch Intern Med. 2001;161:1717–23.CrossRef Lotufo PA, Gaziano JM, Chae CU, et al. Diabetes and all cause and coronary heart disease mortality among US male physicians. Arch Intern Med. 2001;161:1717–23.CrossRef
16.
Zurück zum Zitat Eberly LE, Cohen JD, Prineas R, Yang L. Intervention Trial Research Group. Impact of incident diabetes and incident non-fatal cardiovascular disease on 18-yr mortality; the multiple risk factor intervention trial experience. Diabetes Care. 2003;26:848–54.CrossRefPubMed Eberly LE, Cohen JD, Prineas R, Yang L. Intervention Trial Research Group. Impact of incident diabetes and incident non-fatal cardiovascular disease on 18-yr mortality; the multiple risk factor intervention trial experience. Diabetes Care. 2003;26:848–54.CrossRefPubMed
17.
Zurück zum Zitat Hu G, Jousilahti P, Qiao Q, Katoh S, Tuomilehto J. Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with and without history of myocardial infarction. Diabetologia. 2005;48:656–61. Hu G, Jousilahti P, Qiao Q, Katoh S, Tuomilehto J. Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with and without history of myocardial infarction. Diabetologia. 2005;48:656–61.
18.
Zurück zum Zitat Cho E, Rimm EB, Stampfer MJ, Willett WC, Hu FB. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol. 2002;40:954–60.CrossRefPubMed Cho E, Rimm EB, Stampfer MJ, Willett WC, Hu FB. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol. 2002;40:954–60.CrossRefPubMed
19.
Zurück zum Zitat Wannamathee SG, Shaper AG, Lennon L. Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease. Heart. 2004;90:1398–403.CrossRef Wannamathee SG, Shaper AG, Lennon L. Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease. Heart. 2004;90:1398–403.CrossRef
20.
Zurück zum Zitat Vaccaro O, Eberly LE, Neaton JD, Yang L, Riccardi G, Stamler J. Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screeners of the Multiple Risk Factor Intervention Trial. Arch Intern Med. 2004;164:1438.CrossRefPubMed Vaccaro O, Eberly LE, Neaton JD, Yang L, Riccardi G, Stamler J. Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screeners of the Multiple Risk Factor Intervention Trial. Arch Intern Med. 2004;164:1438.CrossRefPubMed
21.
Zurück zum Zitat ACC/AHA. Guideline update for exercise testing: Summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to update the 1997 exercise testing guidelines). JACC. 1997;2002(40):1531–40. ACC/AHA. Guideline update for exercise testing: Summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to update the 1997 exercise testing guidelines). JACC. 1997;2002(40):1531–40.
22.
Zurück zum Zitat ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM. Appropriate use criteria for cardiac radionuclide imaging. A report of the American College of Cardiology Foundation appropriate use task force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society of Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. Circulation. 2009;119:e561–87. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM. Appropriate use criteria for cardiac radionuclide imaging. A report of the American College of Cardiology Foundation appropriate use task force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society of Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. Circulation. 2009;119:e561–87.
23.
Zurück zum Zitat Holly TA, Abbott BG, Al-Mallah M, et al. Single photon-emission computed tomography. J Nucl Cardiol. 2010;17(5):941–73.CrossRefPubMed Holly TA, Abbott BG, Al-Mallah M, et al. Single photon-emission computed tomography. J Nucl Cardiol. 2010;17(5):941–73.CrossRefPubMed
24.
Zurück zum Zitat Barmpouletos D, Stavens G, Ahlberg AW, Katten DM, O’Sullivan DM, Heller GV. Duration and type of therapy for diabetes: Impact on cardiac risk stratification with stress electrocardiographic-gated SPECT myocardial perfusion imaging. J Nuc Cardiol. 2010;17:1041–9.CrossRef Barmpouletos D, Stavens G, Ahlberg AW, Katten DM, O’Sullivan DM, Heller GV. Duration and type of therapy for diabetes: Impact on cardiac risk stratification with stress electrocardiographic-gated SPECT myocardial perfusion imaging. J Nuc Cardiol. 2010;17:1041–9.CrossRef
25.
Zurück zum Zitat Young LH, Wackers FJ, Chyun DA, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: The DIAD study: A randomized controlled trial. JAMA. 2009;301:1547–55.CrossRefPubMedPubMedCentral Young LH, Wackers FJ, Chyun DA, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: The DIAD study: A randomized controlled trial. JAMA. 2009;301:1547–55.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Ghatak A, Padala S, Katten DM, et al. Risk stratification among diabetic patients undergoing stress myocardial perfusion imaging. J. Nucl Cardiol. 2013;20:529–38.CrossRefPubMed Ghatak A, Padala S, Katten DM, et al. Risk stratification among diabetic patients undergoing stress myocardial perfusion imaging. J. Nucl Cardiol. 2013;20:529–38.CrossRefPubMed
27.
Zurück zum Zitat Haffner SM, D’Agostino R, Saad MF, et al. Carotid artery atherosclerosis in Type 2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The Insulin Resistance Atherosclerosis Study). Am J Cardiol. 2000;85:1395–400.CrossRefPubMed Haffner SM, D’Agostino R, Saad MF, et al. Carotid artery atherosclerosis in Type 2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The Insulin Resistance Atherosclerosis Study). Am J Cardiol. 2000;85:1395–400.CrossRefPubMed
28.
Zurück zum Zitat Liao YF, Feng Y, Chen L, Zeng T, Yu F, Hu L. Coronary heart disease risk equivalence in diabetes and arterial diseases characterized by endothelial function and endothelial progenitor cell. J Diabetes Its Complicat. 2014;28:214–8.CrossRef Liao YF, Feng Y, Chen L, Zeng T, Yu F, Hu L. Coronary heart disease risk equivalence in diabetes and arterial diseases characterized by endothelial function and endothelial progenitor cell. J Diabetes Its Complicat. 2014;28:214–8.CrossRef
29.
Zurück zum Zitat Vigen R, Ayers C, Willis B, Defina L, Berry JD. Association of cardiorespiratory fitness with total, cardiovascular, and noncardiovascular mortality across 3 decades of follow-up in men and women. Circ Cardiovasc Qual Outcomes. 2012;5(3):358–64.CrossRefPubMedPubMedCentral Vigen R, Ayers C, Willis B, Defina L, Berry JD. Association of cardiorespiratory fitness with total, cardiovascular, and noncardiovascular mortality across 3 decades of follow-up in men and women. Circ Cardiovasc Qual Outcomes. 2012;5(3):358–64.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Kokkinos P, Myers J, Faselis C, et al. Exercise capacity and mortality in older men: a 20-year follow-up study. Circulation. 2010;122(8):790–7.CrossRefPubMed Kokkinos P, Myers J, Faselis C, et al. Exercise capacity and mortality in older men: a 20-year follow-up study. Circulation. 2010;122(8):790–7.CrossRefPubMed
31.
Zurück zum Zitat Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793–801.CrossRefPubMed Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793–801.CrossRefPubMed
32.
Zurück zum Zitat Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: A meta-analysis. JAMA. 2009;301(19):2024–35.CrossRefPubMed Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: A meta-analysis. JAMA. 2009;301(19):2024–35.CrossRefPubMed
33.
Zurück zum Zitat Nylen ES, Kokkinos P, Myers J, Faselis C. Prognostic effect of exercise capacity on mortality in older adults with diabetes mellitus. J Am Geriatr Soc. 2010;58:1850–4.CrossRefPubMed Nylen ES, Kokkinos P, Myers J, Faselis C. Prognostic effect of exercise capacity on mortality in older adults with diabetes mellitus. J Am Geriatr Soc. 2010;58:1850–4.CrossRefPubMed
Metadaten
Titel
Coronary risk equivalence of diabetes assessed by SPECT-MPI
verfasst von
Donna Chelle V. Morales, DO
Sanjeev P. Bhavnani, MD
Alan W. Ahlberg, MA
Raja C. Pullatt, MD
Deborah M. Katten, RN, MPH
Donna M. Polk, MD, MPH
Gary V. Heller, MD, PhD
Publikationsdatum
06.12.2017
Verlag
Springer International Publishing
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 4/2019
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-017-1114-6

Weitere Artikel der Ausgabe 4/2019

Journal of Nuclear Cardiology 4/2019 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.